These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 30305805)
1. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ Thromb J; 2018; 16():27. PubMed ID: 30305805 [TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery. Osei SK; Long GW; Sharrak A; Derias N; Goodson R; Callahan RE; Studzinski DM; Brown OW J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):543-552. PubMed ID: 36574902 [TBL] [Abstract][Full Text] [Related]
3. An investigation of sickle cell trait, body mass index, and fitness in relation to venous thromboembolism among African American adults. Nelson DA; Deuster PA; O'Connor FG; Edgeworth DB; Kurina LM J Thromb Haemost; 2021 Sep; 19(9):2216-2224. PubMed ID: 34105875 [TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124 [TBL] [Abstract][Full Text] [Related]
5. Ancestry-independent risk of venous thromboembolism in individuals with sickle cell trait vs factor V Leiden. Lin KH; Granka JM; Shastri AJ; Bonham VL; Naik RP Blood Adv; 2024 Nov; 8(21):5710-5718. PubMed ID: 39255335 [TBL] [Abstract][Full Text] [Related]
6. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 outcomes in patients with sickle cell disease and sickle cell trait compared with individuals without sickle cell disease or trait: a systematic review and meta-analysis. Michelon I; Vilbert M; Pinheiro IS; Costa IL; Lorea CF; Castonguay M; Tran TH; Forté S EClinicalMedicine; 2023 Dec; 66():102330. PubMed ID: 38162948 [TBL] [Abstract][Full Text] [Related]
8. Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease. Ziyadah MS; Mansory EM; Alahwal HM; Bahashwan SM; Almohammadi AT; Radhwi OO; Alghamdi T; Khan SA; Almashjary MN; Barefah AS J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892636 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies. Fazal ZA; Avina-Galindo AM; Marozoff S; Kwan J; Lu N; Avina-Zubieta JA BMC Rheumatol; 2024 Feb; 8(1):5. PubMed ID: 38308337 [TBL] [Abstract][Full Text] [Related]
11. Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum? Pintova S; Cohen HW; Billett HH PLoS One; 2013; 8(5):e64141. PubMed ID: 23717554 [TBL] [Abstract][Full Text] [Related]
12. High incidence of venous thromboembolism recurrence in patients with sickle cell disease. Brunson A; Keegan T; Mahajan A; White R; Wun T Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115 [TBL] [Abstract][Full Text] [Related]
13. Gout and risk of venous thromboembolism: A systematic review and meta-analysis of cohort studies. Guo Y; Zhou F; Xu H Int J Rheum Dis; 2023 Feb; 26(2):344-353. PubMed ID: 36549889 [TBL] [Abstract][Full Text] [Related]
14. Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis. Hillary T; Clijmans J; Vermeire S; Lambert J; Garmyn M; Imbrechts M; Vanassche T Ann Med; 2021 Dec; 53(1):1074-1081. PubMed ID: 34184588 [TBL] [Abstract][Full Text] [Related]
15. Sickle-Cell Trait as a Risk Factor for an Unprovoked Venous Thromboembolism: A Case Report. Cross JD; Mackey BP; Yasmin U Cureus; 2023 Dec; 15(12):e51142. PubMed ID: 38283520 [TBL] [Abstract][Full Text] [Related]
16. Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis. Jara-Palomares L; van Es N; Praena-Fernandez JM; Le Gal G; Otten HM; Robin P; Piccioli A; Lecumberri R; Religa P; Rieu V; Rondina M; Beckers M; Prandoni P; Salaun PY; Di Nisio M; Bossuyt PM; Kraaijpoel N; Büller HR; Carrier M Thromb Res; 2019 Apr; 176():79-84. PubMed ID: 30780008 [TBL] [Abstract][Full Text] [Related]
17. Psychotic, Mood, and Anxiety Disorders and Venous Thromboembolism: A Systematic Review and Meta-Analysis. Kowal C; Peyre H; Amad A; Pelissolo A; Leboyer M; Schürhoff F; Pignon B Psychosom Med; 2020; 82(9):838-849. PubMed ID: 32947580 [TBL] [Abstract][Full Text] [Related]
18. The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction. Gaskill T; Pullen M; Bryant B; Sicignano N; Evans AM; DeMaio M Am J Sports Med; 2015 Nov; 43(11):2714-9. PubMed ID: 26391861 [TBL] [Abstract][Full Text] [Related]
19. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Kakkos SK; Caprini JA; Geroulakos G; Nicolaides AN; Stansby G; Reddy DJ; Ntouvas I Cochrane Database Syst Rev; 2016 Sep; 9(9):CD005258. PubMed ID: 27600864 [TBL] [Abstract][Full Text] [Related]
20. Statin use and the prevention of venous thromboembolism: a meta-analysis. Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]